Home » Topics » Regulatory » Patents

Patents
RSS

Novel immunomodulatory agents described by Takeda

March 12, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

New antitumor and immunosuppressive compounds in development at Klinge

March 12, 1998

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

March 12, 1998

P&U scientists disclose new MMP inhibitors for connective tissue diseases

March 12, 1998

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Antimigraine agent for nasal or oral administration disclosed by Pierre Fabre

March 11, 1998

SmithKline Beecham claims indolines for CNS disorders

March 11, 1998

Allergan develops retinoid-like compounds

March 11, 1998

New potassium channel activators from American Home

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.